Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Travoprost Five Day Posology Study
NCT01114893Phase 2Completed
- Sponsor
- Alcon Inc.
- Start
- Apr 2010
- Primary completion
- May 2010
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of travoprost in open-angle glaucoma (OAG), ocular hypertension, sponsored by Alcon Inc.. Started Apr 2010; status: completed.
02
Drugs
travoprost
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT01114893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01114893.